IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo.

Saved in:
Bibliographic Details
Title: IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo.
Authors: Lin CC; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine National Taiwan University Taipei Taiwan., Yao CY; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan., Wang YH; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan., Hsu YC; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan., Yuan CT; Graduate Institute of Clinical Medicine, College of Medicine National Taiwan University Taipei Taiwan.; Department of Pathology Graduate Institute of Oncology College of Medicine National Taiwan University Taipei Taiwan.; Department of Pathology National Taiwan University Cancer Center Taipei Taiwan., Chen TC; Graduate Institute of Clinical Medicine, College of Medicine National Taiwan University Taipei Taiwan.; Division of Hematology and Medical Oncology Department of Internal Medicine Taichung Veterans General Hospital Taipei Taiwan., Hsu CL; Department of Medical Research National Taiwan University Cancer Center Taipei Taiwan., Lee SH; Division of Cellular Therapy Department of Integrated Diagnostics and Therapeutics National Taiwan University Hospital Taipei Taiwan., Lee JY; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan., Shih PT; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan., Kao CJ; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan., Chuang PH; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan., Kuo YY; Tai-Cheng Stem Cell Therapy Center National Taiwan University Taipei Taiwan., Hou HA; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan., Chou WC; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan., Tien HF; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan.; Division of Hematology and Medical Oncology Department of Internal Medicine Far Eastern Memorial Hospital New Taipei Taiwan.
Source: EJHaem [EJHaem] 2024 Jul 28; Vol. 5 (4), pp. 738-748. Date of Electronic Publication: 2024 Jul 28 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39157630
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lin+CC%22">Lin CC</searchLink>; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine National Taiwan University Taipei Taiwan.<br /><searchLink fieldCode="AU" term="%22Yao+CY%22">Yao CY</searchLink>; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan.<br /><searchLink fieldCode="AU" term="%22Wang+YH%22">Wang YH</searchLink>; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan.<br /><searchLink fieldCode="AU" term="%22Hsu+YC%22">Hsu YC</searchLink>; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.<br /><searchLink fieldCode="AU" term="%22Yuan+CT%22">Yuan CT</searchLink>; Graduate Institute of Clinical Medicine, College of Medicine National Taiwan University Taipei Taiwan.; Department of Pathology Graduate Institute of Oncology College of Medicine National Taiwan University Taipei Taiwan.; Department of Pathology National Taiwan University Cancer Center Taipei Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+TC%22">Chen TC</searchLink>; Graduate Institute of Clinical Medicine, College of Medicine National Taiwan University Taipei Taiwan.; Division of Hematology and Medical Oncology Department of Internal Medicine Taichung Veterans General Hospital Taipei Taiwan.<br /><searchLink fieldCode="AU" term="%22Hsu+CL%22">Hsu CL</searchLink>; Department of Medical Research National Taiwan University Cancer Center Taipei Taiwan.<br /><searchLink fieldCode="AU" term="%22Lee+SH%22">Lee SH</searchLink>; Division of Cellular Therapy Department of Integrated Diagnostics and Therapeutics National Taiwan University Hospital Taipei Taiwan.<br /><searchLink fieldCode="AU" term="%22Lee+JY%22">Lee JY</searchLink>; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.<br /><searchLink fieldCode="AU" term="%22Shih+PT%22">Shih PT</searchLink>; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.<br /><searchLink fieldCode="AU" term="%22Kao+CJ%22">Kao CJ</searchLink>; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.<br /><searchLink fieldCode="AU" term="%22Chuang+PH%22">Chuang PH</searchLink>; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.<br /><searchLink fieldCode="AU" term="%22Kuo+YY%22">Kuo YY</searchLink>; Tai-Cheng Stem Cell Therapy Center National Taiwan University Taipei Taiwan.<br /><searchLink fieldCode="AU" term="%22Hou+HA%22">Hou HA</searchLink>; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan.<br /><searchLink fieldCode="AU" term="%22Chou+WC%22">Chou WC</searchLink>; Department of Laboratory Medicine National Taiwan University Hospital Taipei Taiwan.; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan.<br /><searchLink fieldCode="AU" term="%22Tien+HF%22">Tien HF</searchLink>; Division of Hematology Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan.; Division of Hematology and Medical Oncology Department of Internal Medicine Far Eastern Memorial Hospital New Taipei Taiwan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101761942%22">EJHaem</searchLink> [EJHaem] 2024 Jul 28; Vol. 5 (4), pp. 738-748. <i>Date of Electronic Publication: </i>2024 Jul 28 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101761942 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2688-6146 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226886146%22">26886146 </searchLink><i>NLM ISO Abbreviation: </i>EJHaem <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39157630
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/jha2.983
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 738
    Titles:
      – TitleFull: IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lin CC
      – PersonEntity:
          Name:
            NameFull: Yao CY
      – PersonEntity:
          Name:
            NameFull: Wang YH
      – PersonEntity:
          Name:
            NameFull: Hsu YC
      – PersonEntity:
          Name:
            NameFull: Yuan CT
      – PersonEntity:
          Name:
            NameFull: Chen TC
      – PersonEntity:
          Name:
            NameFull: Hsu CL
      – PersonEntity:
          Name:
            NameFull: Lee SH
      – PersonEntity:
          Name:
            NameFull: Lee JY
      – PersonEntity:
          Name:
            NameFull: Shih PT
      – PersonEntity:
          Name:
            NameFull: Kao CJ
      – PersonEntity:
          Name:
            NameFull: Chuang PH
      – PersonEntity:
          Name:
            NameFull: Kuo YY
      – PersonEntity:
          Name:
            NameFull: Hou HA
      – PersonEntity:
          Name:
            NameFull: Chou WC
      – PersonEntity:
          Name:
            NameFull: Tien HF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 07
              Text: 2024 Jul 28
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2688-6146
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: EJHaem
              Type: main
ResultId 1